Rancho Santa Fe, CA, United States of America

Nikolay Filippovich Savchuk

This inventor holds 17 USPTO granted patents and 21 published patent applications and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Alla Chem, LLC, Asavi LLC, Avincuro Pharmaceuticals, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikolay Filippovich Savchuk. Retrieved from https://idiyas.com/inventor/nikolay-filippovich-savchuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 21)

% Patents Active = 17.6

EPO Patents = 2 (Patent Applications = 12)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 51(Granted Patents)

Location History:

Rancho Santa Fe, CA (2013)
Moscow, RU (2017)
Rancho Santa Fe, CA (US) (2012 - 2023)

Company Filing History:

Avincuro Pharmaceuticals, Inc.

patent

4. 13 out of 834,708

Other

patents

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Antiviral Agents

Combination Therapy

Serotonin Receptor Antagonists

Nucleoside Derivatives

Heterocyclic Inhibitors

Pyrazolo Compounds

Pharmaceutical Compositions

Medicinal Chemistry

Disease Treatment

COVID-19

SARS-CoV-2

Therapeutic Methods

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721883 - Antiviral agent for combined therapy of COVID-19 (SARS-CoV-2) (2026-09-01),

2. 11648300 - Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19 (2023-05-16),

3. 10266558 - Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof (2019-04-23),

4. 9655886 - Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for use thereof (2017-05-23),

5. 8829009 - [object Object] (2014-09-09),

6. 8629154 - Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereof (2014-01-14),

7. 8618114 - Substituted 3-arylsulfonyl-pyrazolo[1,5-A]pyrimidines, serotonin 5-HT6 receptor antagonists and methods for the production and use thereof (2013-12-31),

8. 8569318 - Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof (2013-10-29),

9. 8552017 - 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof (2013-10-08),

10. 8552005 - [object Object] (2013-10-08),

11. 8541437 - Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereof (2013-09-24),

12. 8486945 - Heterocyclic inhibitors of an Hh-signal cascade, medicinal compositions based thereon and methods for treating diseases caused by the aberrant activity of an Hh-signal system (2013-07-16),

13. 8486936 - Antagonist of smoothened (2013-07-16),

14. 8481587 - Substituted 2-(5-hydroxy-2-methyl-1H-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases (2013-07-09),

15. 8471009 - (EN) 2-alkylamino-3-arylsulfonyl-cycloalcano [e OR d] pyrazolo [1,5-A]pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof (2013-06-25),

Title: Innovations of Nikolay Filippovich Savchuk

Introduction

Nikolay Filippovich Savchuk is a prominent inventor based in Rancho Santa Fe, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapies for viral infections. With a total of 17 patents, his work has garnered attention for its potential impact on public health.

Latest Patents

Savchuk's latest patents include a groundbreaking pharmaceutical combination therapy aimed at the prevention and treatment of SARS-CoV-2 and related diseases, including COVID-19. This innovative therapy utilizes aprotinin, ribavirin, and nirmatrelvir to combat the virus and associated complications such as pneumonia. Another notable patent involves macroheterocyclic nucleoside derivatives and their analogues, which have been recognized for their potential as chemotherapeutic agents in treating viral infections and cancer.

Career Highlights

Throughout his career, Savchuk has worked with various companies, including Alla Chem, LLC. His research has focused on the development of nucleosides and nucleotides, which have been essential in clinical treatments for nearly five decades. His contributions to the pharmaceutical field have positioned him as a key figure in the ongoing fight against viral diseases.

Collaborations

Savchuk has collaborated with notable individuals in his field, including Andrey Alexandrovich Ivashchenko and Alexander Vasilievich Ivashchenko. These partnerships have facilitated the advancement of his research and the successful development of innovative therapies.

Conclusion

Nikolay Filippovich Savchuk's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and research continue to pave the way for new treatments that could significantly improve health outcomes for patients worldwide.

Profile summary based on public USPTO records.